Back to Search
ROBERT MOOREHEAD, MD
MD
Specialist
NPI: 1619942976Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Type I insulin-like growth factor receptor induces pulmonary tumorigenesis.
PMID 19568412·Neoplasia·2009
7-preclinical
Reversibility and recurrence of IGF-IR-induced mammary tumors.
PMID 19377512·Oncogene·2009
7-preclinical
ABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer.
PMID 19139114·Mol Cancer Ther·2009
7-preclinical
Characterization of a novel primary mammary tumor cell line reveals that cyclin D1 is regulated by the type I insulin-like growth factor receptor.
PMID 18505926·Mol Cancer Res·2008
7-preclinical
The impact of transgenic IGF-IR overexpression on mammary development and tumorigenesis.
PMID 19002570·J Mammary Gland Biol Neoplasia·2008
6-review
The Spy1/RINGO family represents a novel mechanism regulating mammary growth and tumorigenesis.
PMID 18483240·Cancer Res·2008
7-preclinical
Epithelial-stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer.
PMID 18036641·Gynecol Oncol·2008
7-preclinical
Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1).
PMID 17154366·J Cell Physiol·2007
7-preclinical
Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formation.
PMID 16953219·Oncogene·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 711 CHESTERFIELD HWY
CHERAW, SC 29520 - Phone
- (843) 537-7881
Quick Facts
- NPI
- 1619942976
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile